Cargando…

Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population

Cysteine altering NOTCH3 variants, which have previously been exclusively associated with the rare hereditary small vessel disease cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, have a population frequency of 1:300 worldwide. Using a large population data...

Descripción completa

Detalles Bibliográficos
Autores principales: Hack, Remco J., Rutten, Julie W., Person, Thomas N., Li, Jiang, Khan, Ayesha, Griessenauer, Christoph J., Abedi, Vida, Lesnik Oberstein, Saskia A.J., Zand, Ramin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678653/
https://www.ncbi.nlm.nih.gov/pubmed/33161844
http://dx.doi.org/10.1161/STROKEAHA.120.030343
_version_ 1783612201854042112
author Hack, Remco J.
Rutten, Julie W.
Person, Thomas N.
Li, Jiang
Khan, Ayesha
Griessenauer, Christoph J.
Abedi, Vida
Lesnik Oberstein, Saskia A.J.
Zand, Ramin
author_facet Hack, Remco J.
Rutten, Julie W.
Person, Thomas N.
Li, Jiang
Khan, Ayesha
Griessenauer, Christoph J.
Abedi, Vida
Lesnik Oberstein, Saskia A.J.
Zand, Ramin
author_sort Hack, Remco J.
collection PubMed
description Cysteine altering NOTCH3 variants, which have previously been exclusively associated with the rare hereditary small vessel disease cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, have a population frequency of 1:300 worldwide. Using a large population database, and taking genotype as a starting point, we aimed to determine whether individuals harboring a NOTCH3 cysteine altering variant have a higher load of small vessel disease markers on brain magnetic resonance imaging than controls, as well as a higher risk of stroke and cognitive impairment. METHODS: A cross-sectional study using integrated clinical, neuroimaging, and whole-exome sequencing data of 92 456 participants from the Geisinger DiscovEHR initiative cohort. The case group consisted of individuals harboring a NOTCH3 cysteine altering variant (n=118). The control group consisted of randomly selected age- and sex-matched individuals who did not have any nonsynonymous variants in NOTCH3 (n=184). Medical records including brain magnetic resonance imagings were evaluated for clinical and neuroimaging findings associated with small vessel disease. Group comparisons were done using Fisher exact test and ordinal logistic regression models. Risk of stroke was assessed using Cox regression. RESULTS: Of the 118 cases, 39.0% were men, mean age 58.1±16.9 years; 12.6% had a history of stroke, compared with 4.9% of controls. The risk of stroke was significantly increased after age 65 years (hazard ratio, 6.0 [95% CI, 1.4–26.3]). Dementia, mild cognitive impairment, migraine with aura and depression were equally prevalent in cases and controls. Twenty-nine cases (25%) and 45 controls (24%) had an available brain magnetic resonance imaging. After age 65 years, cases had a higher white matter lesion burden and more lacunes. A severe small vessel disease phenotype compatible with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy was rarely seen. CONCLUSIONS: Cysteine altering NOTCH3 variants are an important contributor to the risk of stroke, lacunes, and white matter hyperintensities in the elderly population.
format Online
Article
Text
id pubmed-7678653
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-76786532020-11-23 Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population Hack, Remco J. Rutten, Julie W. Person, Thomas N. Li, Jiang Khan, Ayesha Griessenauer, Christoph J. Abedi, Vida Lesnik Oberstein, Saskia A.J. Zand, Ramin Stroke Original Contributions Cysteine altering NOTCH3 variants, which have previously been exclusively associated with the rare hereditary small vessel disease cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, have a population frequency of 1:300 worldwide. Using a large population database, and taking genotype as a starting point, we aimed to determine whether individuals harboring a NOTCH3 cysteine altering variant have a higher load of small vessel disease markers on brain magnetic resonance imaging than controls, as well as a higher risk of stroke and cognitive impairment. METHODS: A cross-sectional study using integrated clinical, neuroimaging, and whole-exome sequencing data of 92 456 participants from the Geisinger DiscovEHR initiative cohort. The case group consisted of individuals harboring a NOTCH3 cysteine altering variant (n=118). The control group consisted of randomly selected age- and sex-matched individuals who did not have any nonsynonymous variants in NOTCH3 (n=184). Medical records including brain magnetic resonance imagings were evaluated for clinical and neuroimaging findings associated with small vessel disease. Group comparisons were done using Fisher exact test and ordinal logistic regression models. Risk of stroke was assessed using Cox regression. RESULTS: Of the 118 cases, 39.0% were men, mean age 58.1±16.9 years; 12.6% had a history of stroke, compared with 4.9% of controls. The risk of stroke was significantly increased after age 65 years (hazard ratio, 6.0 [95% CI, 1.4–26.3]). Dementia, mild cognitive impairment, migraine with aura and depression were equally prevalent in cases and controls. Twenty-nine cases (25%) and 45 controls (24%) had an available brain magnetic resonance imaging. After age 65 years, cases had a higher white matter lesion burden and more lacunes. A severe small vessel disease phenotype compatible with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy was rarely seen. CONCLUSIONS: Cysteine altering NOTCH3 variants are an important contributor to the risk of stroke, lacunes, and white matter hyperintensities in the elderly population. Lippincott Williams & Wilkins 2020-11-09 2020-12 /pmc/articles/PMC7678653/ /pubmed/33161844 http://dx.doi.org/10.1161/STROKEAHA.120.030343 Text en © 2020 The Authors. Stroke is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial-NoDerivs (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited, the use is noncommercial, and no modifications or adaptations are made.
spellingShingle Original Contributions
Hack, Remco J.
Rutten, Julie W.
Person, Thomas N.
Li, Jiang
Khan, Ayesha
Griessenauer, Christoph J.
Abedi, Vida
Lesnik Oberstein, Saskia A.J.
Zand, Ramin
Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population
title Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population
title_full Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population
title_fullStr Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population
title_full_unstemmed Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population
title_short Cysteine-Altering NOTCH3 Variants Are a Risk Factor for Stroke in the Elderly Population
title_sort cysteine-altering notch3 variants are a risk factor for stroke in the elderly population
topic Original Contributions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7678653/
https://www.ncbi.nlm.nih.gov/pubmed/33161844
http://dx.doi.org/10.1161/STROKEAHA.120.030343
work_keys_str_mv AT hackremcoj cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation
AT ruttenjuliew cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation
AT personthomasn cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation
AT lijiang cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation
AT khanayesha cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation
AT griessenauerchristophj cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation
AT abedivida cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation
AT lesnikobersteinsaskiaaj cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation
AT zandramin cysteinealteringnotch3variantsareariskfactorforstrokeintheelderlypopulation